Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.

by Birgit Engesæter, Olav Engebraaten, Vivi Ann Flørenes, Gunhild Mari Mælandsmo
Published 2012-01-01

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

by Birgit Engesæter, Bianca van Diermen Hidle, Mona Hansen, Pia Moltu, Kjersti Mangseth Staby, Siri Borchgrevink-Persen, Olav K. Vintermyr, Stefan Lönnberg, Mari Nygård, Emiel A. M. Janssen, Philip E. Castle, Irene Kraus Christiansen
Published 2016-11-01